Your browser doesn't support javascript.
loading
Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH.
Cornell, Robert; Hari, Parameswaran; Tang, Shijie; Biran, Noa; Callander, Natalie; Chari, Ajai; Chhabra, Saurabh; Fiala, Mark A; Gahvari, Zhubin; Gandhi, Ujjawal; Godby, Kelly; Gupta, Ridhi; Jagannath, Sundar; Jagosky, Megan; Kang, Yubin; Kansagra, Ankit; Kauffman, Michael; Kodali, Saranya; Kumar, Shaji K; Lakshman, Arjun; Liedtke, Michaela; Lonial, Sagar; Ma, Xiwen; Malek, Ehsan; Mansour, Joshua; McGehee, Elizabeth F; Neppalli, Amarendra; Paul, Barry; Richardson, Paul; Scott, Emma C; Shacham, Sharon; Shah, Jatin; Siegel, David S; Umyarova, Elvira; Usmani, Saad Z; Varnado, William; Vij, Ravi; Costa, Luciano.
Afiliação
  • Cornell R; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Hari P; Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Tang S; Karyopharm Therapeutics Inc, Newton, Massachusetts.
  • Biran N; John Theurer Cancer Center Hackensack University, Hackensack, New Jersey.
  • Callander N; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin.
  • Chari A; Mount Sinai School of Medicine, New York, New York.
  • Chhabra S; Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Fiala MA; Washington University School of Medicine, St. Louis, Missouri.
  • Gahvari Z; Scripps Clinic, La Jolla, California.
  • Gandhi U; UNC REX Healthcare, Cary, North Carolina.
  • Godby K; University of Alabama at Birmingham, Birmingham, Alabama.
  • Gupta R; Stanford University School of Medicine, Stanford, California.
  • Jagannath S; Mount Sinai Hospital, New York, New York.
  • Jagosky M; Levine Cancer Institute/Atrium Health, Charlotte, North Carolina.
  • Kang Y; Duke University School of Medicine, Durham, North Carolina.
  • Kansagra A; University of Texas Southwestern Medical Center, Dallas, Texas.
  • Kauffman M; Karyopharm Therapeutics Inc, Newton, Massachusetts.
  • Kodali S; University of Vermont, College of Medicine, Burlington, Vermont.
  • Kumar SK; Mayo Clinic, Rochester, Minnesota.
  • Lakshman A; Department of Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Liedtke M; Stanford University School of Medicine, Stanford, California.
  • Lonial S; Emory University, Atlanta, Georgia.
  • Ma X; Karyopharm Therapeutics Inc, Newton, Massachusetts.
  • Malek E; Case Western Reserve University, Cleveland, Ohio.
  • Mansour J; City of Hope Comprehensive Center, Duarte, California.
  • McGehee EF; Kaiser Permanente Medical Group, Los Angeles, California.
  • Neppalli A; University of Texas Southwestern Medical Center, Dallas, Texas.
  • Paul B; Medical University of South Carolina, Charleston, South Carolina.
  • Richardson P; Levine Cancer Institute/Atrium Health, Charlotte, North Carolina.
  • Scott EC; Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Shacham S; Oregon Health & Science University, Portland, Oregon.
  • Shah J; Karyopharm Therapeutics Inc, Newton, Massachusetts.
  • Siegel DS; Karyopharm Therapeutics Inc, Newton, Massachusetts.
  • Umyarova E; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey.
  • Usmani SZ; University of Vermont, College of Medicine, Burlington, Vermont.
  • Varnado W; Levine Cancer Institute/Atrium Health, Charlotte, North Carolina.
  • Vij R; University of Alabama at Birmingham, Birmingham, Alabama.
  • Costa L; Washington University School of Medicine, St. Louis, Missouri.
Am J Hematol ; 96(1): E5-E8, 2021 01.
Article em En | MEDLINE | ID: mdl-32974944

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Bases de Dados Factuais / Mieloma Múltiplo Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Bases de Dados Factuais / Mieloma Múltiplo Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article